 Adverum Biotechnologies NASDAQ:ADVM was upgraded by stock analysts at ValuEngine from a hold rating to a buy rating in a report released on Monday, ValuEngine reports. A number of other research firms have also recently issued reports on ADVM. SunTrust Banks upgraded shares of Adverum Biotechnologies from a hold rating to a buy rating and ... 